BAUSCH HEALTH COMPANIES INC

NYSE: BHC (Bausch Health Companies Inc.)

Kemas kini terakhir: 05 Jul, 3:00AM

7.06

-0.06 (-0.84%)

  • 1H -0.84%
  • 5H 23.64%
  • 1B 9.97%
  • 6B 11.01%
  • Tahun Ke Tarikh -11.08%
  • 1T 23.00%
  • 5T -60.49%
Penutupan Terdahulu 7.12
Buka 7.12
Jumlah Dagangan 1,160,876
Purata Dagangan (3B) 2,546,949
Modal Pasaran 2,609,022,976
Harga / Pendapatan (P/E Ke hadapan) 1.53
Harga / Jualan (P/S) 0.220
Julat 52 Minggu
3.96 (-43%) — 9.85 (39%)
Tarikh Pendapatan 30 Jul 2025
Margin Keuntungan -0.41%
Margin Operasi (TTM) 13.15%
EPS Cair (TTM) -0.120
Pertumbuhan Hasil Suku Tahunan (YOY) 4.90%
Pertumbuhan Pendapatan Suku Tahunan (YOY) -61.50%
Nisbah Semasa (MRQ) 1.35
Aliran Tunai Operasi (OCF TTM) 1.60 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 1.57 B
Pulangan Atas Aset (ROA TTM) 4.37%
Pulangan Atas Ekuiti (ROE TTM) -2,304.54%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - Specialty & Generic (US) Menaik Bercampur
Drug Manufacturers - Specialty & Generic (Global) Menaik Bercampur
Stok Bausch Health Companies Inc. Menaik Menurun

AISkor Stockmoo

-1.3
Konsensus Penganalisis 2.0
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal -2.5
Osilator Teknikal -2.5
Purata -1.25

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
BHC 3 B - - -
ZTS 71 B 1.16% 28.85 13.12
TAK 48 B 1,358.28% 65.78 1.01
HLN 47 B 1.60% 25.04 2.01
RDY 11 B 54.73% 17.58 2.91
TEVA 19 B - - 2.58

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Sektor Healthcare
Industri Drug Manufacturers - Specialty & Generic
Gaya Pelaburan Mid Value
% Dimiliki oleh Orang Dalam 10.98%
% Dimiliki oleh Institusi 69.04%

Pemilikan

Nama Tarikh Syer Dipegang
Paulson & Co. Inc. 31 Mar 2025 26,439,035
39.9539.9531.1031.1022.2522.2513.4013.404.554.55Harga Sasaran MedianQ3 '20Q3 '20Q4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

  • 3M
Tarikh Jenis Butiran
07 Aug 2025 Pengumuman Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners
30 Jul 2025 Pengumuman Bausch Health Announces Second Quarter 2025 Results
29 Jul 2025 Pengumuman Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
29 Jul 2025 Pengumuman Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
28 Jul 2025 Pengumuman Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand
24 Jul 2025 Pengumuman Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
10 Jul 2025 Pengumuman CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs
10 Jul 2025 Pengumuman Bausch Health Appoints New Chief Accounting Officer
09 Jul 2025 Pengumuman Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs
07 Jul 2025 Pengumuman Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
02 Jul 2025 Pengumuman Bausch Health to Announce Second Quarter 2025 Results on July 30
Papar semua
Purata Hasil Dividen 5T 0.00%
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
10 Nov 2010 04 Nov 2010 22 Dec 2010 1 Tunai
30 Aug 2010 05 Aug 2010 04 Oct 2010 0.095 Tunai
28 May 2010 06 May 2010 05 Jul 2010 0.095 Tunai
04 Mar 2010 25 Feb 2010 05 Apr 2010 0.09 Tunai
30 Nov 2009 05 Nov 2009 04 Jan 2010 0.09 Tunai
28 Aug 2009 06 Aug 2009 05 Oct 2009 0.09 Tunai
13 May 2009 06 May 2009 06 Jul 2009 0.09 Tunai
06 Mar 2009 26 Feb 2009 06 Apr 2009 0.375 Tunai
19 Dec 2008 06 Nov 2008 05 Jan 2009 0.375 Tunai
21 Aug 2008 13 Aug 2008 03 Sep 2008 0.375 Tunai
20 May 2008 08 May 2008 30 May 2008 0.375 Tunai
25 Mar 2008 13 Mar 2008 03 Apr 2008 0.375 Tunai
16 Nov 2007 08 Nov 2007 30 Nov 2007 0.375 Tunai
16 Aug 2007 08 Aug 2007 31 Aug 2007 0.375 Tunai
18 May 2007 10 May 2007 29 May 2007 0.375 Tunai
22 Mar 2007 15 Mar 2007 03 Apr 2007 0.375 Tunai
08 Jan 2007 06 Dec 2006 22 Jan 2007 0.5 Tunai
20 Nov 2006 09 Nov 2006 30 Nov 2006 0.125 Tunai
16 Aug 2006 10 Aug 2006 01 Sep 2006 0.125 Tunai
19 May 2006 11 May 2006 31 May 2006 0.125 Tunai
05 Apr 2006 23 Mar 2006 28 Apr 2006 0.125 Tunai
28 Nov 2005 15 Nov 2005 14 Dec 2005 0.5 Tunai
15 Nov 2005 03 Nov 2005 01 Dec 2005 0.0775 Tunai
17 Aug 2005 04 Aug 2005 01 Sep 2005 0.0775 Tunai
11 Apr 2005 10 Mar 2005 27 Apr 2005 0.0775 Tunai
10 Jan 2005 29 Dec 2004 26 Jan 2005 0.0775 Tunai
08 Oct 2004 01 Oct 2004 27 Oct 2004 0.0775 Tunai
12 Jul 2004 30 Jun 2004 28 Jul 2004 0.0775 Tunai
12 Apr 2004 03 Mar 2004 28 Apr 2004 0.0775 Tunai
12 Jan 2004 19 Dec 2003 28 Jan 2004 0.0775 Tunai
06 Oct 2003 15 Sep 2003 29 Oct 2003 0.0775 Tunai
09 Jul 2003 01 Jul 2003 25 Jul 2003 0.0775 Tunai
07 Apr 2003 04 Mar 2003 23 Apr 2003 0.0775 Tunai
06 Jan 2003 20 Dec 2002 22 Jan 2003 0.0775 Tunai
09 Oct 2002 02 Oct 2002 23 Oct 2002 0.0775 Tunai
08 Jul 2002 01 Jul 2002 24 Jul 2002 0.0775 Tunai
08 Apr 2002 14 Mar 2002 24 Apr 2002 0.0775 Tunai
07 Jan 2002 19 Dec 2001 23 Jan 2002 0.075 Tunai
05 Oct 2001 25 Sep 2001 24 Oct 2001 0.075 Tunai
09 Jul 2001 12 Jun 2001 25 Jul 2001 0.075 Tunai
09 Apr 2001 23 Feb 2001 25 Apr 2001 0.075 Tunai
10 Jan 2001 04 Jan 2001 29 Jan 2001 0.0725 Tunai
12 Oct 2000 02 Oct 2000 30 Oct 2000 0.0725 Tunai
18 Jul 2000 06 Jul 2000 03 Aug 2000 0.0725 Tunai
20 Apr 2000 11 Apr 2000 10 May 2000 0.0725 Tunai
25 Jan 2000 18 Jan 2000 10 Feb 2000 0.07 Tunai
08 Oct 1999 04 Oct 1999 27 Oct 1999 0.07 Tunai
12 Jul 1999 22 Jun 1999 28 Jul 1999 0.07 Tunai
12 Apr 1999 22 Mar 1999 28 Apr 1999 0.07 Tunai
20 Jan 1999 12 Jan 1999 01 Feb 1999 0.06 Tunai
09 Oct 1998 29 Sep 1998 28 Oct 1998 0.06 Tunai
06 Jul 1998 24 Jun 1998 22 Jul 1998 0.06 Tunai
06 Apr 1998 30 Mar 1998 22 Apr 1998 0.06 Tunai
12 Jan 1998 31 Dec 1997 28 Jan 1998 0.08 Tunai
06 Oct 1997 29 Sep 1997 22 Oct 1997 0.08 Tunai
07 Jul 1997 26 Jun 1997 23 Jul 1997 0.08 Tunai
07 Apr 1997 25 Mar 1997 23 Apr 1997 0.08 Tunai
11 Feb 1997 31 Jan 1997 27 Feb 1997 0.077 Tunai
18 Oct 1996 08 Oct 1996 05 Nov 1996 0.077 Tunai
09 Jul 1996 28 Jun 1996 25 Jul 1996 0.077 Tunai
26 Mar 1996 14 Mar 1996 10 Apr 1996 0.077 Tunai
04 Dec 1995 24 Nov 1995 20 Dec 1995 0.07 Tunai
31 Aug 1995 22 Aug 1995 19 Sep 1995 0.07 Tunai
23 May 1995 17 May 1995 14 Jun 1995 0.07 Tunai
Papar semua

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2010 1.37 5 4.84
2009 0.930 4 6.66
2008 1.13 3 11.91
2007 2.00 5 14.86
2006 0.500 4 2.36
2005 0.810 5 3.41
2004 0.310 4 1.88
2003 0.310 4 1.44
2002 0.308 4 1.16
2001 0.298 4 0.53
2000 0.288 4 0.74
1999 0.270 4 1.15
1998 0.260 4 2.75
1997 0.317 4 3.25
1996 0.231 3 3.61
1995 0.210 3 3.26
Papar semua
7.027.026.476.475.915.915.365.364.814.81Jul 30Jul 30Jul 31Jul 31Aug 1Aug 1Aug 4Aug 4Aug 5Aug 5Aug 6Aug 6Aug 7Aug 7Aug 8Aug 8

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
0.3000.3000.2000.2000.1000.1000.0000.000-0.100-0.100MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda